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ABSTRACT 
Objectives. The objective of our study was to compare the health status of the Roma people with that 
of the general population in Hungary. 
Methods. A health examination survey to define the prevalence of metabolic syndrome and its 
components was performed in a representative random sample (n=646) of the Roma population aged 
20-64 years living in segregated colonies and data were compared to that obtained in a representative 
random sample (n=1819) of the Hungarian population. 
Results. The risks for central obesity, hypertension and raised triglyceride level among Roma adults 
were not differed from the Hungarian references, while raised fasting plasma glucose or known type 2 
diabetes mellitus (OR=2.65, 95%CI 1.90-3.69), reduced HDL cholesterol level or treated lipid 
disorder (OR=2.15, 95%CI 1.65-2.79) were significantly more frequent in all age groups in the Roma 
sample. The prevalence of metabolic syndrome (OR=1.37, 95%CI 1.03-1.83) was also significantly 
higher among Roma than in the general Hungarian population. 
Conclusions. Besides tackling the socioeconomic determinants of the poor health of Roma people, 
specific public health interventions considering increased genetic susceptibility to metabolic 
disturbances are needed to improve their health status. 
KEYWORDS Roma, health examination survey, metabolic syndrome, genetic background 
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INTRODUCTION 
Roma are the largest ethnic minority in Europe with an estimated number between 12 and 15 million1 
Their representation in the population is greatest in Bulgaria, Romania, Slovakia, Hungary, the Czech 
Republic and Slovenia, but the EU enlargements of 2004 and 2007 has enabled increasing numbers to 
migrate into and to settle in other countries of the EU. The Roma are concentrated in economically 
deprived regions, often living in segregated parts (colonies) characterized by severely unfavorable 
environmental conditions of human habitats.2 Independently of the country where they live in, the 
common problems that this population group experiences are poverty, restricted access to education, 
high level of unemployment and social exclusion.3 
On the base of the predominantly low socio-economic status of the Roma population and socio-
economical status as determinant of health, it is a reasonable assumption that their health status is 
much worse and their average life expectancy is much shorter than that of the majority population, as 
is frequently mentioned both in research and public communications.4,5,6,7Considering the fact that 
recording Roma ethnicity is not permitted in any kind of official documentation including medical 
records, birth and death certificates8 as well as some major obstacles that hinder or prevent the 
collection of reliable data on Roma and other minorities,9 these cannot be considered as evidence 
proved. 
In a longitudinal study covering the entire population of Bulgaria between 1992-98 in 2011 Kohler 
and Preston10 presented “the first reliable life table measures and cause-specific mortality indicators 
according to ethnicity and religion” by linking data in the 1992 census to subsequent death records. 
Although identification of Roma found to be the least reliable among the groups considered and they 
were most likely to be misclassified resulting in undercounting, their mortality was found to be very 
high compared to all other ethnic/religious groups according to nearly all major causes of death. 
Although many studies have documented high prevalence of communicable diseases,11,12fewer have 
documented non-communicable diseases among the Roma people (see reviewed13). Even fewer 
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studies have compared Roma health status with that of the majority population, and even if 
comparisons were made they were restricted to one or only a few (hypertension, diabetes) health 
indicators.14,15 In addition, the comparative studies were mainly questionnaire-based health interview 
surveys when self-assessed health status and functional limitations were considered as outcome 
indicators, and no medical examinations were carried out. The ethnic identification of individuals can 
also be contested.16 
The objective of our study was to compare the health status of the Roma people with that of the 
general population in Hungary. We conducted a study measuring the prevalence of metabolic 
syndrome and its components which overcomes the limitations with the existing evidence-base on 
Roma health noted above. 
- First, it is a definitive health examination survey from the epidemiological point of view. 
- Second, it targets health status of Roma in complexity by investigating the prevalence of 
metabolic syndrome as well as the prevalence of its components as it was defined by the 
International Diabetes Federation Consensus Group.17 Although the definition and clinical 
interpretation of metabolic syndrome is a subject of intense scientific discussion18 there is a 
general agreement that it is the most robust predictor of the increased susceptibility to 
different non-communicable diseases (cardiovascular diseases, type 2 diabetes, polycystic 
ovary syndrome, fatty liver, cholesterol gallstones, asthma, sleep disturbances, and some 
forms of cancer)19 most of them with high morbidity and mortality burden. 
- Third, data are compared with reference data of the majority population in Hungary. 
- Fourth, by involving representatives of the Roma population at all stages of the study high 
level validity has been reached through avoiding the misclassification of the study subjects 
and low response rate of selected Roma adults. 
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METHODS 
Sampling 
A nationwide project surveyed the segregated colonies (SCs) in Hungary. Roma field workers 
nominated by the Roma non-governmental organizations identified the SCs. 94% of SCs’ inhabitants 
declared themselves to be Roma.20 
The present investigation utilized this colony-registry in stratified multistep sampling. The study 
embraced 2 Hungarian counties (Hajdu-Bihar and Szabolcs-Szatmar-Bereg), where Roma colonies are 
accumulated. To focus the investigation to the highly segregated, closed Roma population, SCs with 
more than 100 inhabitants were considered as the study base. Of the 64 eligible SCs 40 and 25 
households from each SC were randomly selected using the General Practitioners’ validated (and 
corrected, if it was needed) household-lists. The 20-64 years old inhabitants of the resulting 1000 
households comprised the final sampling frame, and 1 person from each household has been chosen by 
a member of the primary health care team using random table. 
Roma Health Examination Survey 
The participants were invited to the GPs’ office where a questionnaire on socio-demographic factors, 
life-style and self-assessed health status was completed by GPs or practice nurses on the basis of 
interviewees’ answers, and physical examination was carried out. The health status description utilized 
the former medical records of participants as well. Blood samples for laboratory investigations were 
taken. Informed consent from the participants was obtained. The data collection started in September 
2011, and took 4 months, and it applied the methods of a former study on the metabolic syndrome 
(Hungarian Metabolic Syndrome Survey, HMSS).20 
Socio-demographic characteristics (age, gender, level of education), results of physical examination 
(body weight, height, waist circumference and blood pressure), serum concentrations of triglyceride, 
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HDL-cholesterol and glucose assessed in fasting blood samples, and the medical history of lipid 
disorders, hypertension and type 2 diabetes mellitus have been processed in the present investigation. 
The consensus definition of the International Diabetes Federation was used to determine the presence 
of metabolic syndrome.17 Applied thresholds: central obesity ≥94 cm for men and ≥80 cm for women; 
serum triglyceride concentration ≥1.7 mmol/l or specific treatment for it; serum HDL cholesterol 
concentration <1.03 mmol/l for men and <1.29 mmol/l for women or specific treatment for it, systolic 
blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg or specific treatment for it, fasting 
plasma glucose level ≥5.6 mmol/l or previously diagnosed type 2 diabetes mellitus. 
Reference data set 
The SCs’ data have been compared to reference values determined by the above mentioned HMSS on 
a representative sample of the Hungarian population (n= 1819).20 The present investigation utilized the 
1542 complete records of 20-64 years old adults from HMSS as reference dataset. 
Data analysis 
The SC specific and the HMSS derived datasets were have been joined. The final SC-HMSS database 
contained anonymized records. The prevalence of metabolic syndrome and that of its components 
were calculated for different strata (age groups in both genders of the samples investigated).  The 
prevalences of the metabolic syndrome and that of its components were estimated for different strata 
(age groups in both genders of the samples investigated) and their 95% confidence intervals were 
computed using the normal distribution. The chi square test was used for the comparison of 
prevalences between both ethnicities and males and females, respectively. The statistical evaluation of 
observed proportions has been carried out by their 95% confidence interval computed using the 
normal distribution and by chi square test. The association of risk-factors of age, gender, education 
and ethnicity on the different health outcomes was analyzed using multiple logistic regression models. 
Stata 10.1 was used for the applied in statistical analyseis. 
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RESULTS 
Because of some non-collaborative GPs, the data collection was impossible in 3 SCs. Therefore, the 
sample contained 925 persons. The informed consent was signed, the questionnaire was completed, 
and the physical examination was undertaken by 725 adults. The records with any missing metabolic 
syndrome related data was excluded from the analysis. Finally, 646 SC-records were analyzed. 
There were remarkable demographic differences between SC and Hungarian reference samples (table 
1). The male proportion was much lower in studied SCs (39.16%) than in representative Hungarian 
sample (47.47%). The age distribution of SC sample was shifted towards the younger age groups, and 
strongly deviated from the Hungarian reference distribution. The level of education was considerably 
lower among SC inhabitants than the national reference. Both in the general Hungarian and the Roma 
populations the prevalence of the raised fasting plasma glucose concentration or formerly diagnosed 
diabetes mellitus, as well as that of the raised triglyceride level or treated lipid disorder were 
significantly more frequent among males, while the frequency of central obesity was higher among 
females. In the general population the prevalence of hypertension was higher among males, but the 
same difference can not be detected in the Roma group (table 2 A and B).  
The central obesity (p<0.001) and the hypertension (p<0.001) were less frequent among SC 
inhabitants in both genders. Contrary, the reduced HDL cholesterol level (p=0.029) and the higher 
fasting blood glucose concentration (p<0.001) were significantly more frequent in the SC sample. The 
raised triglyceride level was similar in the studied samples (p=0.084). Altogether, the observed 
prevalence data of metabolic syndrome in SC (36.38%) and control Hungarian (34.96%) samples were 
not deviated from each other (p=0.525). (table 2 C, D and E) 
The age specific prevalence estimates show that the central obesity and the hypertension were less 
frequent only among older CS inhabitants. On the other hand, the reduced HDL cholesterol levels and 
higher fasting blood glucose concentrations were manifested in almost every age group (figure 1). 
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In multivariate model, the age proved to be significant risk factor for metabolic syndrome (OR=1.06, 
95%CI 1.05-1.07) and for every of its components (table 3). Apart from the decreased HDL 
cholesterol level, all the studied outcomes were significantly influenced by gender: the central obesity 
was more frequent among women; other components and the metabolic syndrome (OR=0.75, 95%CI 
0.62-0.91) were associated with the male gender. The studied outcomes were independent of the 
education. Raised fasting plasma glucose or known type 2 diabetes mellitus (OR=2.65, 95%CI 1.90-
3.69), reduced HDL cholesterol level or treated lipid disorder (OR=2.15, 95%CI 1.65-2.79), and 
consequently, the metabolic syndrome (OR=1.37, 95%CI 1.03-1.83) were more frequent among SCs’ 
inhabitants. 
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DISCUSSION 
Roma, the largest minority population of Europe shows an accumulation in the Central, Eastern and 
Southern (CES) European countries, so the problems related to this low educated, typically 
unemployed, marginalized population living in deep poverty were considered as regional challenges of 
CES countries. The opening of borders in the process of previous and ongoing EU expansion has 
enabled increasing numbers of Roma to settle in other parts of the EU and has focused attention on the 
need to address Roma exclusion not only at national, but also international level and has highlighted 
Roma problems as common European challenges.21,22 Recent changes to Canada’s immigration 
legislation (Bill C-31) clearly show that the Roma problems do not respect even the continental 
borders. 
Over the past decades, a series of national and international policy initiatives have been designed to 
improve the situation of the Roma, and EU-wide policy networks focusing on education, employment, 
housing and health have also been established to support Roma inclusion.21,23 Unfortunately, there has 
been limited assessment of actual outputs and results of the projects benefiting Roma inclusion and 
improving Roma health.24 Additionally, new concern has been raised that the current economic crisis 
may disproportionately affect vulnerable communities, including the Roma.25 
Epidemiological studies on health of the Roma people were focused almost exclusively on 
communicable diseases and reproductive health before the turn of millennium,26 and research has only 
recently extended to the field of non-communicable diseases and their risk factors. These studies are 
limited in number, and have severe uncertainties on the identification of Roma ethnicity and are 
restricted to one or a few indicators. Most of these studies can not be really conclusive, because no 
comparison was made with the overall population. Some others which make comparison report 
contradictory findings: some studies show no difference between Roma and non-Roma populations in 
the cardiovascular disease (CVD) occurrence,27 while others report increased prevalence of various 
CVD risks among Roma.11,12,13,14 
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A comparative study of the CVD risk profile for a sample of 430 adult Roma living in rural Croatia 
compared with those for the general Croatian population was recently published.28 The findings 
indicated that the Roma population bear a high CVD risk load related to smoking and high glucose 
level; and a higher prevalence of CVD risks in women and the higher body mass index in younger age 
group (18-34 years) characteristic for the Roma population were in contrast to the findings in the 
general population of Croatia. However, although the components were targeted in the study, the 
prevalence of metabolic syndrome was not defined. 
Until now only a single report29 tried to estimate the prevalence of metabolic syndrome among Roma 
and concluded that it is high. The small sample size (N=77), as well as the method used for sampling 
(Roma people who visited the GPs with different complaints were included) excludes the possibility to 
get scientifically acceptable estimates. The reported 50.6% prevalence can be interpreted as an 
overestimate. 
In our present study the sample frame and size was almost identical with those we previously used in a 
comparative health interview survey30 and data obtained in the Roma sample have been compared to 
reference values determined in the HMMS.20 The prevalence of every components of metabolic 
syndrome showed continuous elevation by age in the Hungarian reference population. Similar pattern 
was observed for Roma only among 20 to 54 years old adults, but further elevation was not observable 
in the 55-59 and 60-64 yrs age groups, values were unchanged (HDL cholesterol) or slightly decreased 
(blood pressure, fasting serum glucose, triglyceride), while the prevalence of central obesity became 
even significantly lower for the 55-59 yrs group of Roma people. The analysis of data with age-group 
stratification clearly shows that the significantly lower prevalence of elevated blood pressure or treated 
hypertension, as well as that of central obesity is the effect of their decreased prevalence in the older 
age groups and not a characteristic of the whole Roma population; it is reasonable to suppose that the 
decrease is a consequence of the deaths of people with risk factors combined before reaching age of 
55. Considering the sex-composition of the Roma sample it can be suggested that mainly the men are 
affected. 
Page 10 of 24
http://mc.manuscriptcentral.com/ejph
Manuscripts submitted to European Journal of Public Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
11 
 
The fact that the prevalence of elevated fasting glucose level and that of decreased HDL cholesterol 
concentration is higher in all age groups of Roma strongly suggest that genetic background exists 
behind these phenomena. A current review summarizing recently published reports on the genetic 
architecture of lipid metabolism reports 52 genes responsible for HDL cholesterol level.31 In a large 
scale epidemiological study (Tehran Lipid and Glucose Study) the estimates of age and gender 
adjusted heritability for abdominal obesity, low HDL cholesterol, high triglyceride, high fasting blood 
glucose and high blood pressure were 22, 40, 34, 38 and 23%, respectively (p<0.05), i.e. the 
contribution of genetic factors was highest to the development of low HDL cholesterol (40%) and high 
fasting blood glucose (38%) levels.32 Concerning genetic determinants of carbohydrate metabolism 
recent genome-wide association studies have identified and replicated 75 susceptibility loci associated 
with type 2 diabetes and related metabolic traits (see reviewed in33). Studies convincingly support the 
hypothesis on the strong influence of the gene-environment interactions in the development of type 2 
diabetes34 and also demonstrate interactions of gene variants with measures of dietary intake and 
exercise.35,36 Although it is generally accepted that in case of metabolic syndrome life-style changes 
are the most adequate therapeutic interventions37,38 and presently there is insufficient support for 
clinical application of gene-based prediction models in metabolic syndrome, there is direction and 
encouraging progress in a rapidly moving field that is beginning to show clinical relevance.39 It has to 
be accepted that careful clinical trial programs are needed to determine which HDL raising therapeutic 
interventions may indeed exert protective effect.40 
The most obvious limitation of the current health examination survey of Roma people was that it was 
not representative of the overall Hungarian Roma population. Those Roma who have assimilated with 
the majority population were excluded, and consequently the survey captured the characteristics of the 
most disadvantaged part of the Roma population. However, identification of the needs of this group is 
the most important from a policy perspective. It is also important to note that the random sample 
representative for the general Hungarian population of the Hungarian Metabolic Syndrome Survey 
have included some people who are Roma, so it is possible that their inclusion was slightly dilute the 
true difference between the populations. 
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Our results show that metabolic syndrome strongly contribute to the development of the poor health 
status of the Roma population. Among the components of metabolic syndrome decreased HDL-C and 
elevated fasting blood glucose levels with genetic predisposition are the most prominent findings, 
which gives specific importance to the screening for these blood components on a regular basis. 
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Keypoints 
• This study shows that the prevalence of metabolic syndrome (MS) is significantly higher among 
Roma than in the general population in Hungary due to the much higher frequency of raised fasting 
plasma glucose (or known type 2 diabetes mellitus) and that of reduced HDL cholesterol level (or 
treated lipid disorder). 
• Reduced HDL cholesterol and the higher fasting blood glucose concentrations were significantly 
more frequent in all age groups of the Roma sample in both genders, which may indicate a genetic 
background. 
• These findings suggest that besides tackling the socioeconomic determinants of the poor health of 
Roma people, specific public health interventions considering increased susceptibility to disturbances 
both in carbohydrate and lipid metabolisms are needed to improve their health status. 
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Table 1 
Socio-demographical characteristics of study samples representative for segregated Roma 
colonies and for Hungarian adult population. 
Socio-demographical factors 
Segregated Roma sample 
(N=646) 
Representative Hungarian sample 
(N=1542) 
Age groups (years) 
20-24 68 (10.53%) 93 (6.03%) 
25-29 59 (9.13%) 157 (10.18%) 
30-34 79 (12.23%) 161 (10.44%) 
35-39 101 (15.63%) 155 (10.05%) 
40-44 117 (18.11%) 171 (11.09%) 
45-49 72 (11.15%) 185 (12%) 
50-54 66 (10.22%) 237 (15.37%) 
55-59 47 (7.28%) 210 (13.62%) 
60-64 37 (5.73%) 173 (11.22%) 
Sex 
Ffemale 393 (60.84%) 810 (52.53%) 
Mmale 253 (39.16%) 732 (47.47%) 
Education 
Lless than primary 250 (38.7%) 31 (2.01%) 
Pprimary 304 (47.06%) 266 (17.25%) 
Vvocational 75 (11.61%) 504 (32.68%) 
Hhigh school 15 (2.32%) 521 (33.79%) 
Uuniversity 1 (0.15%) 204 (13.23%) 
Mmissing 1 (0.15%) 16 (1.04%) 
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Table 2 
Ethicity- and gender-specific prevalence of metabolic syndrome and its components among 20-64 years old Hungarians (A) and inhabitants of 
segregated Roma colonies (B), compared with each other (C, D, E). 
Metabolic syndrome 
components 
A. Representative Hungarian sample by 
gender 
B. Segregated Roma sample by gender C. Studied sample by ethnicity 
D. Segregated 
Roma vs. 
Representative 
Hungarian males 
E. Segregated 
Roma vs. 
Representative 
Hungarian females 
Females 
(N=810) 
Males 
(N=732) 
p 
Females 
(N=393) 
Males (N=253) p 
Segregated 
Roma sample 
(N=646) 
Representative 
Hungarian 
sample (N=1542) 
p p p 
Central obesity 
76.17% 
[73.25-79.09] 
62.43% 
[58.94-65.92] 
0.013 
66.16% 
[61.5-70.81] 
52.17% 
[46.05-58.30] 
0.076 
60.68% 
[56.91-64.45] 
69.65% 
[67.35-71.94] 
<0.001 0.004 <0.001 
Raised blood pressure or 
treated hypertension 
44.32% 
[40.92-47.72] 
53.01% 
[49.41-56.60] 
0.045 
38.68% 
[33.89-43.47] 
43.08% 
[37.01-49.15] 
0.469 
40.40% 
[36.62-44.19] 
48.44% 
[45.95-50.94] 
<0.001 0.007 0.063 
Raised fasting plasma glucose 
concentration or formerly 
diagnosed diabetes mellitus 
10.49% 
[8.39-12.59] 
21.17% 
[18.23-24.12] 
<0.001 
21.88% 
[17.82-25.95] 
35.18% 
[29.32-41.03] 
0.005 
27.09% 
[23.66-30.52] 
15.56% 
[13.75-17.37] 
<0.001 <0.001 <0.001 
Raised triglyceride level or 
treated lipid disorder 
31.36% 
[28.18-34.54] 
44.95% 
[41.36-48.53] 
<0.001 
28.24% 
[23.82-32.67] 
42.69% 
[36.62-48.75] 
0.008 
33.90% 
[30.25-37.55] 
37.81% 
[35.39-40.23] 
0.084 0.533 0.271 
Reduced HDL cholesterol level 
or treated lipid disorder 
34.2% 
[30.95-37.45] 
38.11% 
[34.61-41.62] 
0.273 
55.73% 
[50.84-60.61] 
51.38% 
[45.26-57.51] 
0.554 
54.02% 
[50.18-57.87] 
36.06% 
[33.66-38.45] 
0.029 <0.001 <0.001 
Metabolic syndrome 
32.72% 
[29.5-35.93] 
37.43% 
[33.94-40.92] 
0.179 
34.86% 
[30.17-39.55] 
38.74% 
[32.76-44.71] 
0.496 
36.38% 
[32.67-40.09] 
34.95% 
[32.57-37.33] 
0.525 0.712 0.460 
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Table 3 Socio-demographical risk factors of metabolic syndrome and its components by multivariate logistic regression model for 20-64 years 
old adults in Hungary (odds ratios and 95% confidence intervals). 
 
Age 
(year) 
Sex 
(Ffemale/ 
Mmale) 
Education* Ethnicity 
(Roma/ 
Hungarian) 
Pprimary Vvocational Hhigh school Uuniversity 
Central obesity 1.06 
[1.05-1.07] 
1.93 
[1.59-2.36] 
1.36 
[0.98-1.90] 
1.44 
[0.98-2.14] 
1.45 
[0.96-2.20] 
1.06 
[0.66-1.71] 
0.84 
[0.63-1.12] 
Raised blood pressure or treated hypertension 1.09 
[1.08-1.10] 
0.62 
[0.51-0.76] 
1.09 
[0.78-1.53] 
1.02 
[0.69-1.53] 
0.85 
[0.56-1.30] 
1.01 
[0.62-1.64] 
0.94 
[0.70-1.26] 
Raised fasting plasma glucose concentration or 
known type 2 diabetes mellitus 1.07 
[1.06-1.08] 
0.40 
[0.31-0.51] 
1.31 
[0.91-1.90] 
1.03 
[0.66-1.62] 
0.72 
[0.44-1.19] 
0.59 
[0.32-1.12] 
2.65 
[1.90-3.69] 
Raised triglyceride level or treated lipid disorder 1.05 
[1.04-1.06] 
0.52 
[0.43-0.62] 
1.21 
[0.87-1.68] 
1.36 
[0.93-2.00] 
1.27 
[0.85-1.90] 
1.35 
[0.85-2.16] 
1.22 
[0.93-1.62] 
Reduced HDL cholesterol level or treated lipid 
disorder 1.02 
[1.02-1.03] 
0.93 
[0.78-1.11] 
0.96 
[0.70-1.30] 
0.96 
[0.67-1.38] 
0.80 
[0.55-1.17] 
0.82 
[0.52-1.27] 
2.15 
[1.65-2.79] 
Metabolic syndrome 1.07 
[1.06-1.08] 
0.75 
[0.62-0.91] 
1.04 
[0.75-1.44] 
0.99 
[0.67-1.46] 
0.89 
[0.60-1.34] 
0.87 
[0.54-1.41] 
1.37 
[1.03-1.83] 
* less than primary education serves as reference category 
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Figure 1  
Age specific prevalence (with 95% confidence interval) of central obesity (a), raised blood pressure or 
treated hypertension (b), raised fasting serum glucose concentrations or formerly diagnosed type 2 diabetes 
mellitus (c), raised serum triglyceride levels or treated lipid disorders (d), reduced serum HDL cholesterol 
levels or treated lipid disorders (e), and metabolic syndrome (f) in 20-64 years old adults’ samples 
representative for the population of Hungary and for the inhabitants of segregated Roma colonies.  
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Ad Figure 1 Age specific prevalence (with 95% confidence interval) of central obesity (a), raised blood 
pressure or treated hypertension (b), raised fasting serum glucose concentrations or formerly diagnosed 
type 2 diabetes mellitus (c), raised serum triglyceride levels or treated lipid disorders (d), reduced serum 
HDL cholesterol concentration or treated lipid disorders (e), and metabolic syndrome (f) in 20-64 years old 
males’ samples representative for Hungary and for segregated Roma colonies in Hajdu-Bihar and Szabolcs-
Szatmar-Bereg counties.  
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Ad Figure 1 Age specific prevalence (with 95% confidence interval) of central obesity (a), raised blood 
pressure or treated hypertension (b), raised fasting serum glucose concentrations or formerly diagnosed 
type 2 diabetes mellitus (c), raised serum triglyceride levels or treated lipid disorders (d), reduced serum 
HDL cholesterol concentration or treated lipid disorders (e), and metabolic syndrome (f) in 20-64 years old 
females’ samples representative for Hungary and for segregated Roma colonies in Hajdu-Bihar and 
Szabolcs-Szatmar-Bereg counties.  
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